We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CEL market cap is 63.41M. The company's latest EPS is GBP -0.2722 and P/E is -3.73.
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 24k |
| Operating Income | -206k | -187k | -722k | -13.51M |
| Net Income | -191k | -175k | -720k | -17.01M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 5.66M | 5.5M | 6.61M | 13.25M |
| Total Liabilities | 33k | 42k | 197k | 6.21M |
| Total Equity | 5.63M | 5.46M | 6.41M | 7.04M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -174k | -160k | -2.71M | -6.1M |
| Investing | N/A | N/A | N/A | 1.39M |
| Financing | 5.82M | N/A | 1.68M | 5.95M |
| Market Cap | 63.41M |
| Price to Earnings Ratio | -3.73 |
| Price to Sales Ratio | 2.54k |
| Price to Cash Ratio | 12.53 |
| Price to Book Ratio | 9.01 |
| Dividend Yield | - |
| Shares Outstanding | 62.47M |
| Average Volume (1 week) | 20.28k |
| Average Volume (1 Month) | 76.53k |
| 52 Week Change | -26.18% |
| 52 Week High | 180.00 |
| 52 Week Low | 77.50 |
| Spread (Intraday) | 7 (6.67%) |
| Company Name | Celadon Pharmaceuticals Plc |
| Address |
32-33 cowcross street london EC1M 6DF |
| Website | https://celadonpharma.co.uk |
| Industry | investment advice (6282) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
